InnoCan Pharma Corporation (INNPF)
OTCMKTS
· Delayed Price · Currency is USD
0.0800
0.00 (0.00%)
Jun 24, 2025, 8:00 PM EDT
InnoCan Pharma Revenue
InnoCan Pharma had revenue of $7.80M in the quarter ending March 31, 2025, with 15.19% growth. This brings the company's revenue in the last twelve months to $30.47M, up 61.49% year-over-year. In the year 2024, InnoCan Pharma had annual revenue of $29.44M with 115.55% growth.
Revenue (ttm)
30.47M
Revenue Growth
+61.49%
P/S Ratio
1.58
Revenue / Employee
n/a
Employees
n/a
Market Cap
48.23M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo, Inc. | 1.73B |
| Elite Pharmaceuticals | 70.00M |
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| American Oncology Network | 1.76B |
| Glass House Brands | 215.62M |
| Northwest Biotherapeutics | 1.47M |
| Silence Therapeutics | 27.70M |
InnoCan Pharma News
- 1 year ago - Innocan Pharma Announces Brokered LIFE Offering of Units for Up to $3 Million - GlobeNewsWire
- 2 years ago - Innocan Pharma Announces Launch of CBD Veterinary Commercialization Team - Newsfile Corp
- 2 years ago - Innocan Pharma Announces First Patent Grant in the United States - Newsfile Corp
- 2 years ago - Innocan Pharma Reports Clinical Success in Canine Compassionate Care Trial - Newsfile Corp
- 2 years ago - Innocan Pharma Provides Annual "State of the Business" Update - Newsfile Corp
- 2 years ago - Innocan Pharma Signs a First Consulting Agreement to Commercialize its Pharmaceutical IP in the Veterinary Field - Newsfile Corp
- 2 years ago - Innocan Pharma Reports Q3 2022 Results with 700% Increase in Revenues Compared to Q3 2021 - Newsfile Corp
- 2 years ago - Mr. Givi Topchishvili to Join Innocan Pharma's Advisory Committee - Newsfile Corp